1. Canada Stocks

  2. •

    Healthcare

  3. •

    Medical - Healthcare Information Services
Treatment.Com International Inc.

Treatment.Com International Inc.

TRUE.CN
Treatment.Com International Inc.CA flagCanadian Securities Exchange
0.51
CAD
-0.01
- -
38.51MMarket Cap

Total Valuation

Treatment.Com International Inc. carries a market capitalization of 38.51M, placing it among publicly traded companies globally. Its enterprise value stands at 22.53M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap38.51M
Enterprise Value22.53M

Share Statistics

Treatment.Com International Inc. currently has 75.50M shares outstanding.

Shares Outstanding75.50M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 42.08, and the price-to-book ratio stands at -5.26.

PE RatioN/A
PS Ratio42.08
PB Ratio-5.26
P/TBV Ratio-2.25
P/FCF Ratio-4.34
P/OCF Ratio-4.34

Enterprise Valuation

EV / Sales43.02
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

Treatment.Com International Inc. maintains a current ratio of 0.09, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 7.58, indicating elevated leverage, while an interest coverage ratio of -458.79 demonstrates limited ability to service its debt obligations.

Current Ratio0.09
Quick Ratio0.03
Debt / Equity7.58
Debt / EBITDA-0.07
Interest Coverage-458.79

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-89.39
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory TurnoverN/A

Stock Price Statistics

Treatment.Com International Inc.'s stock has declined approximately -28.16901% over the past 52 weeks. The 50-day moving average sits at 0.45, while the 200-day moving average is 0.49.

Beta (5Y)N/A
52-Week Price Change-28.16901%
50-Day Moving Average0.45
200-Day Moving Average0.49
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Treatment.Com International Inc. generated 523,746.00 in revenue and converted that into -8.75M in net income, yielding earnings per share of -0.16. EBITDA reached -8.30M, while operating income came in at -8.30M.

Revenue523,746.00
Gross Profit457,161.00
Operating Income-8.30M
Pretax Income-8.75M
Net Income-8.75M
EBITDA-8.30M
EBIT-8.30M
Earnings Per Share (EPS)-0.16

Balance Sheet

Treatment.Com International Inc. holds 117,595.00 in cash and equivalents against 613,455.00 in total debt, resulting in a net debt position of 495,860.00. Total book value stands at -4.19M, with working capital of -6.32M providing operational flexibility.

Cash & Cash Equivalents117,595.00
Total Debt613,455.00
Net Debt495,860.00
Equity (Book Value)-4.19M
Book Value Per Share-0.08
Working Capital-6.32M

Cash Flow

Treatment.Com International Inc. produced -5.08M in operating cash flow over the past twelve months.

Operating Cash Flow-5.08M
Capital ExpendituresN/A
Free Cash Flow-5.08M
FCF Per Share-0.09

Margins

Treatment.Com International Inc. operates with a gross margin of 89.39, reflecting its pricing power and cost economics. The operating margin of -1,585.60 and net profit margin of -1,670.11 provide insight into operational efficiency.

Gross Margin89.39
Operating Margin-1,585.60
Pretax Margin-1,670.11
Profit Margin-1,670.11
EBITDA Margin-1,585.60

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-25.39
FCF Yield-23.04

Stock Splits

Treatment.Com International Inc.'s most recent stock split took place on July 14, 2023 with a 10:1 split ratio.

Last Split Date7/14/2023
Split Ratio10:1

Scores

Treatment.Com International Inc. posts an Altman Z-Score of -138.17, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-138.17